scispace - formally typeset
Journal ArticleDOI

Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Reads0
Chats0
TLDR
The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection.
Abstract
The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection. The current analysis includes more than 6000 patients and updated risk factors for continuous flow pumps. Among continuous flow pumps, actuarial survival is 80% at 1 year and 70% at 2 years. Quality of life indicators are generally favorable and adverse event burden will likely influence patient selections of advanced heart failure therapies.

read more

Citations
More filters
Journal ArticleDOI

Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

TL;DR: The epidemiology, pathophysiology, causes, and outcomes of cardiogenic shock are summarized; contemporary best medical, surgical, mechanical circulatory support, and palliative care practices are reviewed; the development of regionalized systems of care is advocated; and future research priorities are outlined.
Journal ArticleDOI

The registry of the international society for heart and lung transplantation: Thirtieth official adult heart transplant report - 2013; Focus theme: Age

TL;DR: This 30th adult heart transplant report is based on data submitted on 110,486 heart transplants in recipients of all ages by 407 centers worldwide since 1982 through June 30, 2012, with follow-up until June 30- 2012.
References
More filters
Journal ArticleDOI

INTERMACS Profiles of Advanced Heart Failure: The Current Picture

TL;DR: Patients considered for mechanical circulatory support can now be classified using the 7 profiles plus 3 modifiers developed through INTERMACS, and understanding these profiles and their impact on outcome should help to better select patients and therapies in the advanced stages of disease.
Journal ArticleDOI

The Fourth INTERMACS Annual Report: 4,000 implants and counting

TL;DR: The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection and provides a risk factor analysis of the entire adult primary implant population.
Journal ArticleDOI

INTERMACS database for durable devices for circulatory support: first annual report.

TL;DR: The background of INTERMACS is reviewed, data analysis for the first 18 months of data collection is reported and the list of approved devices for mechanical circulatory support for advanced heart failure is listed.
Journal ArticleDOI

Third INTERMACS Annual Report: the evolution of destination therapy in the United States.

TL;DR: The third annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) provides documentation of the current landscape of durable mechanical circulatory support in the United States.
Related Papers (5)